GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Sells $309,338.96 in Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Roland Rott sold 3,577 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

GE HealthCare Technologies Trading Down 1.6 %

GEHC stock traded down $1.39 during midday trading on Wednesday, reaching $86.78. The company’s stock had a trading volume of 4,159,525 shares, compared to its average volume of 3,004,006. The business’s 50-day simple moving average is $88.74 and its 200-day simple moving average is $83.46. The stock has a market cap of $39.65 billion, a PE ratio of 23.53, a price-to-earnings-growth ratio of 3.12 and a beta of 1.24. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.99 earnings per share. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.30%.

Analysts Set New Price Targets

A number of analysts recently commented on GEHC shares. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. One analyst has rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $94.36.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors have recently added to or reduced their stakes in the business. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies in the third quarter worth $26,000. Pathway Financial Advisers LLC bought a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Finally, Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies in the 2nd quarter worth $26,000. 82.06% of the stock is owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.